The levels of c-myc and c-fos mRNA were investigated in rat skeletal muscle by Northern hybridization. During post-natal development in the rat, c-myc mRNA levels were similar at birth and at 7 and 21 days of age, but then declined at 90 days and were barely detectable at 1 year. c-fos mRNA levels followed this pattern of expression until 90 days, but showed a large increase at 1 year. Hypertrophy of soleus and plantaris muscles was induced either by severance of the tendon to the synergistic gastrocnemius (tenotomy) or by administration of the 83-adrenoceptor agonist clenbuterol. In both cases hypertrophy was associated with a rapid increase in c-myc mRNA levels. Following tenotomy the increase was both greater (8-fold) and more rapid (3 h) in soleus than in plantaris (2-3 fold, 12 h). Similar effects were observed during clenbuterol administration. Neither treatment caused any alteration in c-fos mRNA levels in the plantaris muscle. The results show that increased c-myc mRNA levels are an early event in the response of skeletal muscle to hypertrophic stimuli; it is argued that this occurs within the differentiated skeletal muscle fibres.
INTRODUCTION
During myogenesis, proliferating undifferentiated myoblasts fuse with one another and become terminally differentiated multinucleate myotubes, which are unable to replicate further (Nadal-Ginard, 1978) . This process involves the down-regulation of genes associated with the cell cycle and the induction of muscle specific genes in a temporal and sequential pattern (Lawrence et al., 1989) . In the rat, myoblast proliferation (hyperplasia) happens mainly during foetal development, and the majority of muscle fibres have formed by birth (Goldspink, 1972) ; subsequent growth of the multinucleated differentiated myofibres occurs by increases in the cellular mass without division of the myonuclei (hypertrophy). The biochemical mechanisms involved in muscle hypertrophy are poorly understood, but in skeletal muscle it has been shown to be associated with changes in the pattern of expression of actin and myosin isoforms (Periasmy et al., 1989) . Similarly, in the adult rat myocardium induced to hypertrophy by pressure overload, the usually adult-muscle-specific mRNAs for ac-actin and fl-tropomyosin are expressed as the foetal isoforms within 2 days (Izumo et al., 1988 ).
An earlier event in cardiac muscle hypertrophy, both in the overloaded heart and in cardiac myocytes stimulated by aadrenergic agonists, is the expression of the proto-oncogenes cmyc and c-fos (Starksen et al., 1986; Mulvagh et al., 1987; Izumo et al., 1988) . These genes are believed to code for transcriptional regulators and have been regarded by some as exclusively involved in the regulation of events leading to mitosis and cell division (Freytag, 1988) . However, particularly in the case of cmyc, the studies of cardiac muscle mentioned above suggest that the products of these genes may have other roles, including some functions in muscle differentiation (see Schneider & Olsen, 1988) . Although c-myc expression is reduced during myotube formation in culture (Schneider & Olsen, 1988) , this decline appears to reflect reduced cell proliferation, and it has been demonstrated that the expression of these oncogenes and muscle-specific genes is not mutually exclusive (Endo & Nadal-Ginard, 1986; Alema & Tato, 1987) . Furthermore, c-myc expression can be stimulated in mature myotubes (Endo & Nadal-Ginard, 1986 ). In particular, the results from the study of cardiac hypertrophy suggest that changes in expression of c-myc and c-fos are part of a sequence of events which lead to cardiac cell hypertrophy (Izumo et at., 1988) .
The aims of the present work were to investigate the expression of c-myc and c-fos in skeletal muscle by measuring the levels of c-myc and c-fos mRNA during post-natal development and hypertrophy. The study employed Northern hybridization and two models of skeletal muscle hypertrophy, one induced by compensatory workload after severance of the tendon to a synergistic muscle, and the other induced pharmacologically using the fl-adrenoceptor agonist clenbuterol.
MATERIALS AND METHODS Chemicals and DNA probes
The c-myc probe, a gift from Dr. M. Cole, Princeton University, NJ, U.S.A., was the cDNA of the 3 exons of the mouse c-myc gene. The 2.3 kbp cDNA was cloned into pT7 and a 1.8 kbp HindIlI fragment was used in hybridization studies. The v-fos probe, a 1.0 kbp Pstl fragment cloned into pBR322 (Curran et al., 1982) , was a gift from Dr. G. Birnie, Beatson Institute, Glasgow, U.K. A probe to 18 S rRNA (Erikson et al., 1981) In further experiments, hypertrophy was induced by the /-adrenoceptor agonist clenbuterol. At 27 days old, male rats were fed a semi-synthetic diet (PW3; Pullar & Webster, 1977) ad libitum for 3 days. The animals were then split into two groups, one fed on PW3 diet only (controls) and the other fed on PW3 containing clenbuterol (2 mg/kg) (Maltin et al., 1986) . In experiments when very early effects (3-6 h) were investigated, clenbuterol was administered orally in a dose equivalent to that which would have been ingested in 3-6 h assuming a daily intake of 10 g of food.
RNA extraction and hybridization
The soleus and plantaris muscles were broken up while frozen and then homogenized in 4 M-guanidinium thiocyanate/25 mMsodium citrate (pH 7.0)/0.5 % sarkosyl/0. 1 M-2-mercaptoethanol (1 ml/100 mg of muscle) using an Ultra-Turrax. Subsequent extraction of total RNA followed the acid/guanidinium/ chloroform procedure of Chomczynski & Sacchi (1987) , proportionally scaled down into microcentrifuge tubes for samples weighing less than 100mg. RNA species were then separated by electrophoresis through a denaturing 2.2 Mformaldehyde/1.20% agarose gel (Maniatis et al., 1982) and transferred to a nylon membrane (Genescreen) by capillary blotting. RNA was fixed to the membrane by exposure to u.v. light and the membranes were stored dry until required.
Membranes were pre-hybridized overnight at 42°C with denatured salmon sperm DNA (0.1 mg/ml) in 50% formamide, 10 % dextran sulphate, 0.2 % BSA, 0.2 % polyvinylpyrrolidone, 0.2 % Ficoll, 0.1 0% sodium pyrophosphate, 1 % SDS and 50 mMTris/HCI, pH 7.5. DNA probes (50-100 ng), which had previously been re-1992 144 Increased c-myc expression during muscle hypertrophy stricted and separated by electrophoresis in a 0.6% low-meltingpoint agarose gel (Gibco-BRL), were labelled with [32P]dCTP by random priming, and the labelled DNA was then separated from free nucleotides by gel filtration on Sephadex G-50; probe specific radioactivities were approx. 109 c.p.m./,ug of DNA. The labelled probes were added to the prehybridization mixture and hybridized at 42°C for 24 h. The membranes were washed to remove non-specific hybridizations, twice in 2 x SSC (1 x SSC = 0.15 M-NaCl/0.015 M-sodium citrate) at room temperature for 5 min, followed by 0.5 x SSC/1 % SDS at 65°C for 1 h (twice). Specific hybridization was then detected by autoradiography using Hyperfilm-MP at -70°C (up to I week for c-myc). After autoradiography, membranes were washed in 0.1 % SDS for 5-7 min at 95°C before rehybridization to other probes.
The absorbance of the bands on the film was quantified using a QUIPS image processing work station (Torch Computers, Cambridge, U.K.) operating with VCS image processing software (Vision Dynamics, Hemel Hempstead, Herts., U.K.).
Autoradiographs were placed on a photographic light box and images were captured with a Hitachi KP 140 CCD camera (resolution 768 x 256 pixels, at 256 grey levels). The level of expression of the c-myc or c-fos mRNA was calculated as the ratio of the intensity of the band after hybridization to the intensity of the band after subsequent hybridization with the probe to the 18 S rRNA; this presents the level of specific mRNA per unit rRNA, and minimizes any variation in loading of the gel. The ratios were then expressed as percentages of the mean value for control tissues on each filter; this enabled direct comparison between filters. Most data were analysed using a two-tailed Student's t test. However, the within-filter variation found in the clenbuterol experiment required a more sophisticated treatment in which data from both groups of animals were subjected to an analysis of variance such that bias, in the form of quadratic trends arising from the position of the signal on the filter, was eliminated from the analysis.
RESULTS
Hybridization of Northern blots showed that both the c-myc and c-fos probes reacted with single RNA species in preparations of total RNA from skeletal muscle (Fig. 1) ; the sizes of the two RNAs detected (2.4 and 2.2 kb) corresponded to the known sizes of the c-myc and c-fos mRNAs. The levels of proto-oncogene mRNA were investigated during the post-natal development of the rat by Northern blotting and hybridizations on total RNA from the muscle of neonatal rats and those aged 7 days, 21 days, 90 days and 1 year. In the neonatal and 7-day-old animals, muscle was taken from the whole leg for analysis, while the gastrocnemius was used from the older animals (females). c-myc mRNA levels were initially relatively high in the neonate and remained so until 21 days of age (Fig. 1) . Thereafter the mRNA declined with age until barely detectable in the 1-year-old female rat. The c-fos mRNA levels followed this pattern of expression from the neonate until 90 days old, but the 1-year-old female rats showed a very large increase in the amount of c-fos mRNA (Fig. 1) .
The early responses to the hypertrophic stimulus of compensatory work overload were investigated 3, 6, 12, 24 and 48 h after tenotomy. Visual inspection of the autoradiographs suggested that the induced workload produced an increase in the amount of c-myc mRNA in both the soleus and plantaris muscles (for example, results for soleus muscle 12 h after tenotomy are shown in Fig. 2) . Quantification of the extent of hybridization (Fig. 3) showed that both the time course and magnitude of the changes in c-myc expression were different in the two muscles.
Thus the soleus muscle responded more rapidly; the c-myc mRNA levels were significantly increased 3 h after tenotomy in the soleus, but not until 12 h in the plantaris. Similarly, the soleus was also more sensitive, as shown by the 7-8-fold increase detected in the soleus (compared with unoperated controls) and the 2-3-fold increase in plantaris. The maximum effect was observed at 3 h in soleus and 24 h in plantaris, after which times the c-myc mRNA levels returned towards control levels. In sham-operated controls both muscles showed very much smaller increases in c-myc mRNA (20-150 % in soleus and 20-30 % in plantaris). Rehybridization of filters with the v-fos probe showed no difference the c-fos mRNA levels between the plantaris muscles from the control, sham-operated and tenotomized animals (Fig. 4) .
The expression of c-myc and c-fos during early stages of hypertrophy were also investigated in the plantaris and soleus muscles of rats given clenbuterol. As after tenotomy, the hypertrophy of both soleus and plantaris muscles induced by clenbuterol was associated with a significant and rapid increase in the level of c-myc mRNA (Fig. 5) . The variation in hybridization achieved with these filters made it impossible to study the time-related changes in c-myc mRNA after clenbuterol administration. However, formal statistical treatment of the data showed that at certain time points (3-24 h in soleus; 6 h in plantaris) clenbuterol did increase c-myc mRNA levels (P < 0.01). There was no evidence of a change in the c-fos levels in the plantaris muscle following the administration of clenbuterol (results not shown).
DISCUSSION
Hybridization of Northern blots of muscle RNA showed that both c-myc and c-fos mRNAs are present in skeletal muscle. Both mRNAs were present in greatest amounts during neonatal and early life, decreased after weaning at 21 days and remained at these lower levels until the animal was fully grown and sexually mature (90 days). The decline in c-myc expression continued into old age and was barely detectable in 1-year-old female rats which had stopped growing. The higher expression in muscle from neonatal and pre-weaning rats compared with 90-day-old rats suggests that the higher c-myc levels occur during the period when there is rapid muscle growth by enlargement of existing fibres. The subsequent decline may reflect either falling expression within myofibres or a gradual decrease in the number of satellite cells in the muscle. c-fos mRNA levels were also low in the 90-day-old rat, but in contrast increased markedly in 1-year-old female animals. A similar increase in c-fos expression in cardiac muscle from rats of 200 days of age has been reported (Komuro et al., 1988) ; however, at present there is no explanation for these findings. Both c-myc and c-fos have been observed previously to be expressed in muscle cell cultures (Claycomb & Lanson, 1987; Schneider & Olsen, 1988) and heart tissue, but in the case of c-fos the culture process was observed to induce expression (Claycomb & Lanson, 1987) . The present results show that these two proto-oncogenes are also expressed in post-natal skeletal muscle tissue.
Furthermore, the level of c-myc mRNA was stimulated 2-8-fold during muscle hypertrophy induced either by severance of the tendon to a synergistic muscle or by clenbuterol. The effects appeared to be independent of muscle type, since they occurred in both the soleus (tonic, largely slow fibres) and plantaris (phasic, largely fast fibres) muscles. The stimulation seen in the tenotomy experiments could theoretically be due to an increase in c-myc mRNA levels in the myofibres, in satellite cells, or in lymphocytes and macrophages induced to proliferate by postoperative inflammation. However, there are several arguments which suggest that the observed increase in c-myc mRNA levels reflects increases within the muscle fibres themselves rather than in satellite cells or proliferating cells of non-myoblast origin. Firstly, the increase seen following tenotomy was much larger than that seen in sham-operated animals compared with unoperated controls. It would thus appear that although lymphatic cell infiltration may account for the increase observed in the sham-operated animals, it cannot explain the large increase in tenotomy.
This view is supported by the observation that in four animals in which complete tenotomy (i.e. severance of tendons to soleus, plantaris and gastrocnemius muscles) was carried out, and in which therefore the soleus and plantaris were not stimulated to hypertrophy, the increases in c-myc mRNA were within the sham levels. For example, in the soleus at 3-12 h after operation the c-myc mRNA/18S rRNA ratio was 171 + 46 (n = 4) compared with a value of 100 for the unoperated controls. In addition, it is unlikely that the differential expression of c-myc mRNA in soleus muscle compared with plantaris muscle could be explained by inflammatory responses. Lastly, c-myc mRNA levels were also increased in hypertrophy induced by the non-surgical method ofclenbuterol administration. Since satellite cells account for such a small proportion (2-10 %) of myonuclei, it is highly improbable that the 2-8-fold increase in c-myc induced within 3-12 h was due to expression in activated satellite cells. Satellite cell activation would be expected to be associated with increased c-fos mRNA levels, so the observed lack of change in c-fos in these experiments also suggests that there was not sufficient activation of satellite cells to account for the increases in c-myc mRNA. We conclude, therefore, that the increased level of c-myc mRNA observed in hypertrophying muscle reflects increased levels within the skeletal muscle fibres. This is consistent with the facts that (1) c-myc mRNA levels change in cardiac:hypertrophy although there are reportedly no satellite cells in the heart (Zak, 1992 146 Increased c-myc expression during muscle hypertrophy 1973), and (2) c-myc expression can be induced in myotubes in culture (Endo & Nadal-Ginard, 1986) .
The increase in c-myc mRNA observed in hypertrophying skeletal muscle is comparable with the increases found in the heart under pressure overload (Izumo et al., 1988; Komuro et al., 1988) and in stimulated cardiomyocytes (Starksen et al., 1986) ; however, in contrast to these earlier studies, the present studies showed no change in c-fos mRNA levels in the plantaris muscle. In the present work, the lack of change of c-fos shows that, at least in the case of the plantaris muscle, the increase in c-myc does not simply reflect a general increase in mRNA synthesis but is a specific response. In quiescent undifferentiated cells c-myc mRNA is one of the early genes to be expressed in response to a mitotic stimulus (Lau & Nathans, 1985) , and in cardiac muscle the induction of a pressure overload results in elevated expression within 3 h (Izumo et al., 1988) . The time course of the changes induced in both soleus and plantaris muscles suggest that an increase in c-myc mRNA is an early occurrence in a sequence of events that is elicited by stimulation of skeletal muscles to hypertrophy; the increase at 3-6 h in soleus precedes increases in muscle protein synthesis and total RNA (Goldberg et al., 1975 ) and elevation of insulin-like growth factor mRNA levels (De Vol et al., 1990) . At present it is unclear whether the increase in c-myc mRNA levels is due to increased gene transcription, increased stability of the mRNA, or a combination of both.
It has been suggested (Goldberg et al., 1975) that in hypertrophy induced by tenotomy the soleus is subjected to a greater workload than the plantaris, and this is reflected in an initially increased rate of muscle growth for the soleus (Morgan & Loughna, 1989) . This may account for the increased sensitivity of the soleus muscle in both the magnitude and speed at which c-myc mRNA levels are elevated when compared with the plantaris. Alternatively, the constant innervation of the tonic soleus muscle (similar to the heart in this respect) may accentuate and accelerate the response induced by tenotomy.
The importance of c-myc in the control of muscle gene expression is illustrated by three observations: (1) the myc protein has regions of sequence similarity with skeletal myogenic factors such as myoDI (Tapscott et al., 1988; Murre et al., 1989) , (2)'transgenic animals expressing excess c-myc show increases in heart size (Jackson et al., 1990) , and (3) cardiac hypertrophy is associated with transient increases in c-myc mRNA levels (Mulvagh et al., 1987; Izumo et al., 1988; Komuro et al., 1988) . The observed increases in c-myc mRNA levels during skeletal muscle hypertrophy support the view that c-myc has an important role in the control of muscle cell growth. They also support the concept that c-myc expression can be induced in terminally differentiated myocytes (Endo & Nadal-Ginard, 1986) and is not exclusively associated with cell proliferation. In conclusion, the increase in c-myc mRNA appears to be an early event in the response of both skeletal and cardiac muscle to hypertrophic stimuli. This suggests that it may trigger a cascade of events, possibly including activation of insulin-like growth factor genes, which can lead to cell growth and hypertrophy in terminally differentiated cells such as those of skeletal and cardiac muscle.
